High-risk GTN — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine)
High-risk GTN (FIGO score ≥7) is treated with EMA-CO multi-agent chemotherapy, achieving cure rates of approximately 85-95%. For ultra-high-risk (score ≥12 or WHO brain/liver metastases), modified EMA-CO or EP-EMA (etoposide-cisplatin alternating with etoposide-methotrexate-actinomycin D) may be used. Serial HCG monitoring guides treatment duration — chemotherapy continues until HCG normalisation plus 6-8 consolidation weeks. UK management is centralised at Charing Cross and Sheffield GTD centres.
Reference: ESMO 2024 GTD; NICE NG; FIGO GTN scoring system; Seckl et al Lancet 2010